Lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in Japanese patients with dyslipidemia.
暂无分享,去创建一个
H. Daida | H. Arai | T. Teramoto | R. Blaustein | K. Ikewaki | A. Johnson‐Levonas | Y. Watanabe | Masayoshi Shirakawa | M. Nakagomi | Yuko Maeda | T. Kakikawa | Hirotaka Numaguchi | A. Johnson-Levonas | Taro Kakikawa